On April 19, Jiangzhong Pharmaceutical (600750) rose 5.33% to close at 13.84 yuan.
The top ten funds with heavy holdings in Jiangzhong Pharmaceuticals are shown in the table below:

Jiangzhong Pharmaceutical's 2021 annual report shows that the company's main business income was 2.874 billion yuan, up 17.72% year-on-year; net profit attributable to shareholders was 506 million yuan, up 6.74% year-on-year; net profit attributable to shareholders was 424 million yuan, down 4.58% year-on-year; among them, in the fourth quarter of 2021, the company's main business income in a single quarter was 936 million yuan, up 32.54% year-on-year; net profit attributable to shareholders was 53.8561 million yuan, down 28.85% year-on-year; net profit attributable to shareholders was 22.3933 million yuan, down 64.41% year-on-year; debt ratio was 23.59%, investment income was -2.3636 million yuan, financial expenses were -22.4208 million yuan, and gross profit margin was 64.34%. In the past 90 days, a total of 1 institution has given the rating of the stock and 1 in excess.
According to the 2021 annual report fund heavy holdings data, there are 73 funds with heavy holdings in this stock, of which the largest number of funds are Dacheng New Industry Mixed. The current scale of Dacheng Xinrui Industry Mixed Industry is 12.572 billion yuan, with a latest net value of 5.933 (March 22), up 0.97% from the previous day and 33.54% in the past year. The current fund manager of this fund is Han Chuang. The public funds in office of Han Chuang include: Dacheng Ruijing Flexible Allocation Mixed A, with a management time from January 2, 2020 to the present, with a yield of 182.36% during the period; Dacheng State-owned Enterprise Reform Flexible Allocation Mixed, with a management time from January 13, 2021 to the present, with a yield of 62.0% during the period; Dacheng Industry Trend Mixed A, with a management time from February 9, 2021 to the present, with a yield of 34.22%.
The top ten heavily held stocks in Dachengxin Industry Mixed are as follows:

and above are compiled by Securities Star based on public information. If you have any questions, please contact us.